Clinical Trial Update: Study of the Effect of the ROX AC1 on Exercise Capacity and Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ROX AC1 for improving exercise capacity and quality of life in patients with chronic obstructive pulmonary disease has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ROX AC1

Snippet

Sponsor: ROX Medical, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED